https://ninho.inca.gov.br/jspui/handle/123456789/2216 Coleção voltada para a inserção de documentos dos diretores e ex-diretores do Hospital do Câncer III (Vila Isabel). 2026-04-04T09:31:05Z https://ninho.inca.gov.br/jspui/handle/123456789/2254 Title: Sarcoma de Mama Authors: Carmo, Pedro Aurélio Ormonde de Abstract: Sarcoma de mama representa 1% dos canceres maligno primários. Realizamos esse estudo com 16 pacientes com sarcoma verdadeiro de mama 1997-01-01T00:00:00Z https://ninho.inca.gov.br/jspui/handle/123456789/2253 Title: Terapêutica das Displasias Mamárias com uma Associação de Vitaminas A, E e B6 Authors: Carmo, Pedro Aurélio Ormonde de 1986-01-01T00:00:00Z https://ninho.inca.gov.br/jspui/handle/123456789/2250 Title: Impact of treatment type on overall survival in elderly brazilian women with breast cancer Authors: Bello, Marcelo Adeodato; Menezes, Raquel Ferreira de; Silva, Brunna de Sousa; Silva, Rafael de Carvalho da; Cavalcanti, Rousiane Silva; Moraes, Thayane de Fátima da Costa; Tonellotto, Fabiana; Aguiar, Suzana Sales de; Martucci, Renata Brum; Bergmann, Anke; Thuler, Luiz Claudio Santos Abstract: Objective: To analyze the survival of elderly patients with breast cancer according to the type of treatment used. Methods: A cohort study of women aged 80 or over with breast cancer registered with the Brazilian National Cancer Institute (Instituto Nacional do Câncer - INCA) between 2008 and 2009 was conducted. Prognosis was analyzed according to the cancer treatment performed: surgery, radiotherapy, or hormone therapy. Analysis of the overall 5-year survival rate was performed using the Kaplan - Meier method, and comparisons of curves were undertaken using the log-rank test. For multiple regression analysis, Cox regression was used, adjusting for age and clinical stage, considering values of p < 0.05 as significant. Data were all analyzed using the statistical package SPSS version 20. Results: 70 women with a mean age of 84.0 ± 3.7 years at diagnosis participated in the study. The median follow-up time was 37.1 months (range 0.5–75.5), and 31 deaths (44.3%) occurred during this time. The median survival time was 51.2 months (95% CI, 44.9–57.4), higher in those who underwent surgery (p = 0.012) and those who had hormone therapy (p=0.001). Treatment with surgery reduced the risk of death by 61.7% (HR 0.3; 95% CI, 0.1–0.6; p = 0.001) when adjusted for clinical stage and age at diagnosis. However, there was no significant benefit from radiotherapy (HR 1.2; 95% CI, 0.5–2.5; p = 0.694). Conclusion: Treatment with surgery and hormone therapy increased the survival of our Brazilian patients with breast cancer aged 80 or over. 2016-01-01T00:00:00Z https://ninho.inca.gov.br/jspui/handle/123456789/2249 Title: Lymphatic/vascular invasion has a negative impact on overall survival and disease-free survival in patients with breast cancer and positive axillary lymph nodes Authors: Bello, Marcelo Adeodato 2020-04-15T00:00:00Z